WallStreetZenWallStreetZen

NASDAQ: ALPN
Alpine Immune Sciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ALPN

Based on 3 analysts offering 12 month price targets for Alpine Immune Sciences Inc.
Min Forecast
$14.00+62.98%
Avg Forecast
$15.67+82.39%
Max Forecast
$17.00+97.9%

Should I buy or sell ALPN stock?

Based on 3 analysts offering ratings for Alpine Immune Sciences Inc.
Strong Buy
Strong Buy
1 analysts 33.33%
Buy
2 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ALPN stock forecasts and price targets.

ALPN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Morgan Stanley
Bottom 11%
11
Strong BuyInitiates Coverage On$17.00+97.90%2023-01-19
SVB Leerink
Top 14%
87
BuyInitiates Coverage On$16.00+86.26%2022-11-21
Oppenheimer
Bottom 13%
13
BuyMaintains$14.00+62.98%2022-10-25

1 of 1

Forecast return on equity

Is ALPN forecast to generate an efficient return?
Company
N/A
Industry
-0.1%
Market
29.08%

Forecast return on assets

Is ALPN forecast to generate an efficient return on assets?
Company
N/A
Industry
0.01%

ALPN earnings per share forecast

What is ALPN's earnings per share in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
-$1.70
Avg 2 year Forecast
-$2.47
Avg 3 year Forecast
-$2.49

ALPN revenue forecast

What is ALPN's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$41.0M+28.96%
Avg 2 year Forecast
$33.4M+4.97%
Avg 3 year Forecast
$47.9M+50.39%
ALPN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ALPN revenue growth forecast

How is ALPN forecast to perform vs Biotechnology companies and vs the US market?
Company
10.35%
Industry
41.6%
Market
8.82%
ALPN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ALPN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ALPN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ALPN$8.59$15.67+82.39%Strong Buy
SIGA$5.46N/AN/A
STOK$8.92$26.60+198.21%Buy
ANIK$26.86$28.50+6.11%Buy
AURA$10.35$25.00+141.55%Buy
View Top Biotech Stocks

Alpine Immune Sciences Stock Forecast FAQ

Is Alpine Immune Sciences Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: ALPN) stock is to Strong Buy ALPN stock.

Out of 3 analysts, 1 (33.33%) are recommending ALPN as a Strong Buy, 2 (66.67%) are recommending ALPN as a Buy, 0 (0%) are recommending ALPN as a Hold, 0 (0%) are recommending ALPN as a Sell, and 0 (0%) are recommending ALPN as a Strong Sell.

If you're new to stock investing, here's how to buy Alpine Immune Sciences stock.

What is ALPN's earnings growth forecast for 2023-2025?

(NASDAQ: ALPN) Alpine Immune Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.18%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.45%.

Alpine Immune Sciences's earnings in 2023 is -$54,065,000.On average, 4 Wall Street analysts forecast ALPN's earnings for 2023 to be -$78,054,536, with the lowest ALPN earnings forecast at -$115,704,371, and the highest ALPN earnings forecast at -$39,945,557. On average, 3 Wall Street analysts forecast ALPN's earnings for 2024 to be -$113,408,650, with the lowest ALPN earnings forecast at -$136,365,866, and the highest ALPN earnings forecast at -$87,237,423.

In 2025, ALPN is forecast to generate -$114,326,938 in earnings, with the lowest earnings forecast at -$145,089,608 and the highest earnings forecast at -$89,074,000.

What is ALPN's revenue growth forecast for 2023-2025?

(NASDAQ: ALPN) Alpine Immune Sciences's forecast annual revenue growth rate of 10.35% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 41.6%, and while it is forecast to beat the US market's average forecast revenue growth rate of 8.82%.

Alpine Immune Sciences's revenue in 2023 is $31,818,000.On average, 3 Wall Street analysts forecast ALPN's revenue for 2023 to be $1,884,006,929, with the lowest ALPN revenue forecast at $1,469,261,856, and the highest ALPN revenue forecast at $2,107,472,475. On average, 3 Wall Street analysts forecast ALPN's revenue for 2024 to be $1,533,542,062, with the lowest ALPN revenue forecast at $215,797,835, and the highest ALPN revenue forecast at $2,548,251,032.

In 2025, ALPN is forecast to generate $2,197,005,619 in revenue, with the lowest revenue forecast at $1,836,577,320 and the highest revenue forecast at $2,557,433,918.

What is ALPN's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: ALPN) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.01%.

What is ALPN's Price Target?

According to 3 Wall Street analysts that have issued a 1 year ALPN price target, the average ALPN price target is $15.67, with the highest ALPN stock price forecast at $17.00 and the lowest ALPN stock price forecast at $14.00.

On average, Wall Street analysts predict that Alpine Immune Sciences's share price could reach $15.67 by Jan 19, 2024. The average Alpine Immune Sciences stock price prediction forecasts a potential upside of 82.39% from the current ALPN share price of $8.59.

What is ALPN's Earnings Per Share (EPS) forecast for 2023-2025?

(NASDAQ: ALPN) Alpine Immune Sciences's current Earnings Per Share (EPS) is -$1.80. On average, analysts forecast that ALPN's EPS will be -$1.70 for 2023, with the lowest EPS forecast at -$2.52, and the highest EPS forecast at -$0.87. On average, analysts forecast that ALPN's EPS will be -$2.47 for 2024, with the lowest EPS forecast at -$2.97, and the highest EPS forecast at -$1.90. In 2025, ALPN's EPS is forecast to hit -$2.49 (min: -$3.16, max: -$1.94).

What is ALPN's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: ALPN) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.